AstraZeneca
The Global Development Medical Director (Late Phase CVRM) leads medical strategy for late-phase clinical programs in cardiovascular, renal and metabolic disease areas. The role ensures clinical trial design and data support benefit-risk assessment, labeling and market access globally while upholding ethical, regulatory and GCP standards. The director partners across functions and geographies to translate scientific capabilities into patient-impacting medicines.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
(Lead) Clinical Director
Roche
Associate Director, Clinical Scientist, Cardiovascular/Metabolic Disease
Regeneron Pharmaceuticals
Medical Director
Servier
Medical Director
Regeneron Pharmaceuticals
CVRM Business Unit Director
American Association of Physicists in Medicine
Clinical Development Director, Obesity/Cardiovascular
lifelancer